Երկիր: Միացյալ Թագավորություն
Լեզու: անգլերեն
Աղբյուրը: VMD (Veterinary Medicines Directorate)
Marbofloxacin
Vetoquinol UK Ltd
QJ01MA93
Marbofloxacin
Expired
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT MARBOCYL 20 mg Tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active Ingredient Marbofloxacin 20mg per tablet FOR A FULL LIST OF EXCIPIENTS, SEE SECTION 6.1 3. PHARMACEUTICAL FORM Tablet 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Marbofloxacin is indicated in the treatment of : skin and soft tissue infections (skinfold pyoderma, impetigo, folliculitis, furunculosis, cellulitis) caused by susceptible strains of organisms. urinary tract infections (UTI) associated or not with prostatitis caused by susceptible strains of organisms. respiratory tract infections caused by susceptible strains of organisms. 4.3 CONTRA-INDICATIONS Marbofloxacin should not be used in dogs aged less than 12 months, or less than 18 months for exceptionally large breeds of dogs, such as Great Danes, Briard, Bernese Bonvier and Mastiffs, with a longer growth period. Not suitable for infections resulting from strict anaerobes, yeast or fungi. Do not use in cats. For the treatment of this species, a 5 mg tablet is available. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Nil 4.5 SPECIAL PRECAUTIONS FOR USE (I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS The fluoroquinolones have been shown to induce erosion of articular cartilage in juvenile dogs and care should be taken to dose accurately especially in young animals. The fluoroquinolones are also known for their potential neurological side effects. Cautious use is recommended in dogs and cats diagnosed as suffering from epilepsy. A low urinary pH could have an inhibitory effect on the activity of marbofloxacin. (II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS In case of accidental ingestion seek med Կարդացեք ամբողջական փաստաթուղթը